Treatment Overview
5-Alpha Reductase Inhibitors (5-ARIs) are a class of oral medications used to treat Benign Prostatic Hyperplasia (BPH) by reducing the size of the prostate over time. These medications block the enzyme 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth. In Korea, 5-ARI therapy is widely available and often used in combination with alpha-blockers to enhance symptom relief and long-term prostate management.
Purpose & Benefits
The main purpose of 5-ARI therapy is to shrink the prostate, reduce urinary obstruction, and prevent progression of BPH. Key benefits include:
- Gradual reduction in prostate size over several months
- Improvement in urinary flow and decrease in urinary frequency and urgency
- Prevention of further prostate enlargement
- Reduced risk of acute urinary retention
- Can be combined with alpha-blockers for faster symptom relief
- Long-term therapy helps maintain urinary function and quality of life
Ideal Candidates
Ideal candidates for 5-ARI medication include:
- Men with enlarged prostates (usually >40cc)
- Patients with moderate to severe BPH symptoms
- Individuals who prefer medication over surgical intervention
- Men at risk of BPH progression or urinary retention
- Patients seeking combination therapy with alpha-blockers for enhanced results
Possible Risks & Complications
Although 5-ARI medications are generally safe, potential side effects may include:
- Decreased libido or sexual desire
- Erectile dysfunction
- Ejaculatory disorders
- Breast tenderness or enlargement (gynecomastia)
- Rare allergic reactions
- Symptoms usually resolve after discontinuation of the medication
Techniques & Technology Used
5-ARI therapy in Korea involves prescription management and monitoring rather than procedural techniques. The process includes:
- Prescription of medications such as finasteride or dutasteride
- Dose adjustment based on symptom response and tolerance
- Periodic evaluation of prostate size through PSA testing and imaging if needed
- Patient education regarding expected timeline of effects and potential side effects
Treatment Process in Korea
The typical 5-ARI medication process includes:
- Initial Consultation: Review of urinary symptoms, prostate size, medical history, and medications
- Diagnostic Testing: Blood tests, urinalysis, PSA testing, and sometimes imaging
- Prescription and Administration: Start of 5-ARI therapy with appropriate dosage
- Follow-Up Monitoring: Symptom assessment at 3–6 months, PSA monitoring, and side effect evaluation
- Long-Term Management: Continuous therapy to maintain symptom control and prevent BPH progression
Recovery & After-Care
Since 5-ARI therapy is non-invasive, “recovery” involves adjusting to the medication and monitoring for side effects:
- Symptom improvement is gradual and may take 3–6 months
- Regular follow-up visits to monitor PSA levels and urinary function
- Sexual side effects, if present, should be discussed with the prescribing physician
- Patients are advised to continue medication as prescribed for optimal results
- Combination with lifestyle modifications (fluid management, bladder training) can enhance outcomes
Results & Longevity
5-ARI therapy provides effective long-term management for BPH:
- Significant reduction in prostate size over several months
- Improvement in urinary flow and reduction in obstructive symptoms
- Lower risk of acute urinary retention and need for surgical intervention
- Combination therapy with alpha-blockers provides faster relief and long-term benefits
- Long-term adherence ensures sustained symptom control and quality of life
Why Korea Is a Top Destination
Korea is a preferred destination for 5-ARI therapy due to:
- Availability of both branded and generic 5-ARI medications
- Experienced urologists providing comprehensive evaluation and monitoring
- Affordable healthcare and medication costs compared to Western countries
- High standards of safety, hygiene, and prescription regulation
- Comprehensive support for international patients, including consultation, translation, and follow-up
Cost Range
The cost of 5-ARI medication in Korea varies depending on the drug and duration of treatment:
- Monthly cost typically ranges from $25 to $100, depending on brand or generic version
- Follow-up consultation fees may range from $50–$100 per visit
- Combination therapy with alpha-blockers may increase monthly cost slightly
Popular Clinics in Korea
Some of the top clinics providing 5-ARI therapy and BPH management in Korea include:
- Seoul Urology & Andrology Clinic
- JK Male Health Center, Seoul
- Korea Men’s Health Institute, Seoul
- VIP Male Clinic, Gangnam
- Dr. Kim’s Urology Clinic, Busan
